| Health / Medical Topics |
Monoclonal Antibody MGA271
An Fc-domain optimized, humanized monoclonal antibody directed against cancer stem cells (CSCs), with potential immunomodulating and antineoplastic activities. After binding of monoclonal antibody MGA271 to an as of yet not elucidated target expressed on CSCs and differentiated tumor cells, this agent may induce an antibody-dependent cell-mediated cytotoxicity (ADCC) against CSCs. CSCs are tumor initiating cells that are able to self-renew and are responsible for tumor cell growth and resistance. (NCI Thesaurus)
YOU MAY ALSO LIKE
The F(ab)2 fragment of Me1-14, a murine IgG2a monoclonal antibody directed against proteoglycan chondroitin sulfate-associated protein expressed by gliomas and melanomas. …
A bispecific antibody containing a patented Trigger antibody and a humanized antibody that targets TAG-72. TAG-72 is overexpressed in a variety…
A monoclonal antibody used to purge leukemia cells from bone marrow.
A murine IgG2a monoclonal antibody that targets CD33, a 67-kD cell surface glycoprotein expressed on myeloid leukemia cells.
A panadenocarcinoma murine monoclonal antibody (MoAb) with potential antineoplastic activity. MoAb m170 recognizes MUC-1 antigen present on the surface of many…
A chimeric murine-human anti-CD4 monoclonal antibody that down regulates T-helper-inducer function. Clinical Trails: Multiple Sclerosis.
